Effect of Central Sensitization on Response to Physical Therapy in Patients With Partial Supraspinatus Tear
1 other identifier
observational
60
0 countries
N/A
Brief Summary
This prospective observational study aims to investigate whether central sensitization influences the response to physical therapy in patients with partial supraspinatus tendon tears. Participants will undergo standardized clinical evaluation before treatment and after a 6-week physical therapy program. Pain intensity, shoulder function, disability, and central sensitization-related symptoms will be assessed using validated outcome measures. The study seeks to determine the relationship between baseline central sensitization status and treatment outcomes, thereby identifying factors that may predict rehabilitation success and support individualized treatment strategies for patients with partial supraspinatus tears.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2026
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2026
CompletedFirst Posted
Study publicly available on registry
June 24, 2026
CompletedStudy Start
First participant enrolled
June 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 30, 2026
June 24, 2026
June 1, 2026
5 months
June 11, 2026
June 17, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Shoulder Pain and Disability Index (SPADI) Total Score
The Shoulder Pain and Disability Index (SPADI) total score will be assessed at baseline, the end of treatment, and 6 weeks after completion of treatment to evaluate changes in pain and shoulder-related disability. A greater reduction in the SPADI total score indicates a better treatment response.
Baseline, Week 3, and Week 6
Secondary Outcomes (1)
Change in Visual Analog Scale (VAS) Pain Score
Baseline, Week 3, and Week 6
Study Arms (2)
Patients with Central Sensitization
Patients with supraspinatus partial-thickness tears who are classified as having central sensitization based on the Central Sensitization Inventory (CSI) at baseline and who receive the standardized physical therapy program.
Patients without Central Sensitization
Patients with supraspinatus partial-thickness tears who are classified as not having central sensitization based on the Central Sensitization Inventory (CSI) at baseline and who receive the same standardized physical therapy program.
Interventions
All participants will receive the same standardized physical therapy and rehabilitation program administered according to routine clinical practice. The treatment program will include therapeutic exercises, stretching, strengthening, range-of-motion exercises, and appropriate physical therapy modalities as determined by the rehabilitation protocol. No experimental intervention or additional procedure will be performed for research purposes. The study is observational and aims to evaluate whether the presence of central sensitization influences the clinical response to the standardized rehabilitation program.
Eligibility Criteria
The study population will consist of adult patients aged 18-65 years who are diagnosed with supraspinatus partial-thickness tears based on clinical examination and magnetic resonance imaging (MRI) and are referred for conservative treatment. Participants will be recruited from the outpatient Physical Medicine and Rehabilitation clinic. Eligible patients who meet the inclusion criteria and provide written informed consent will be enrolled consecutively. All participants will receive the same standardized physical therapy and rehabilitation program and will be evaluated at baseline, at the end of treatment, and 6 weeks after completion of treatment.
You may qualify if:
- Adults aged 18 to 65 years. Diagnosis of supraspinatus partial-thickness tear confirmed by clinical examination and magnetic resonance imaging (MRI).
- Presence of shoulder pain for at least 6 weeks. Candidates for a standardized physical therapy and rehabilitation program. Ability to understand the study procedures and provide written informed consent.
You may not qualify if:
- Full-thickness rotator cuff tear or history of previous shoulder surgery on the affected side.
- Acute fracture, shoulder dislocation, or other major traumatic injury involving the affected shoulder.
- Inflammatory rheumatic diseases, active infection, or malignancy affecting the musculoskeletal system.
- Neurological disorders that may influence pain perception or upper extremity function (e.g., stroke, cervical myelopathy, peripheral neuropathy).
- Severe glenohumeral or acromioclavicular osteoarthritis requiring surgical treatment.
- Receipt of corticosteroid injection or any invasive shoulder intervention within the previous 3 months.
- Participation in another structured rehabilitation program for the affected shoulder within the previous 3 months.
- Pregnancy or inability to comply with the study protocol or complete the required questionnaires.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Specialist Physician in Physical Medicine and Rehabilitation
Study Record Dates
First Submitted
June 11, 2026
First Posted
June 24, 2026
Study Start
June 30, 2026
Primary Completion (Estimated)
November 15, 2026
Study Completion (Estimated)
November 30, 2026
Last Updated
June 24, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
No. Individual participant data collected during this study will not be shared publicly because of participant confidentiality and institutional data protection policies.